SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001549595-24-000131
Filing Date
2024-10-11
Accepted
2024-10-11 16:05:50
Documents
75
Period of Report
2024-08-31

Document Format Files

Seq Description Document Type Size
1 10-Q nrix-20240831.htm   iXBRL 10-Q 1565618
2 EX-10.1 ex101_nurixare26amendmentn.htm EX-10.1 44203
3 EX-10.2 ex102_nurixare26amendmentn.htm EX-10.2 38988
4 EX-10.3 ex103_nurixare26amendmentn.htm EX-10.3 30935
5 EX-10.4 ex104_nurixare19amendmentn.htm EX-10.4 29179
6 EX-31.1 nrix-20240831x10qxex311.htm EX-31.1 10855
7 EX-31.2 nrix-20240831x10qxex312.htm EX-31.2 10845
8 EX-32.1 nrix-20240831x10qxex321.htm EX-32.1 8428
14 image_0.jpg GRAPHIC 69740
15 image_01.jpg GRAPHIC 12696
16 image_02.jpg GRAPHIC 12696
17 image_03.jpg GRAPHIC 69740
  Complete submission text file 0001549595-24-000131.txt   6876125

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nrix-20240831.xsd EX-101.SCH 43499
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nrix-20240831_cal.xml EX-101.CAL 54071
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nrix-20240831_def.xml EX-101.DEF 210739
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nrix-20240831_lab.xml EX-101.LAB 583032
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nrix-20240831_pre.xml EX-101.PRE 393066
77 EXTRACTED XBRL INSTANCE DOCUMENT nrix-20240831_htm.xml XML 677005
Mailing Address 1700 OWENS STREET, SUITE 205 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET, SUITE 205 SAN FRANCISCO CA 94158 (415) 660-5320
Nurix Therapeutics, Inc. (Filer) CIK: 0001549595 (see all company filings)

IRS No.: 270838048 | State of Incorp.: DE | Fiscal Year End: 1130
Type: 10-Q | Act: 34 | File No.: 001-39398 | Film No.: 241367608
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)